1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 46. Medina M, Tran A L, Bhakta K, Klatt R A, Miller J L. Tips for writing pharmacy residency letters of intent. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2020; 77 : 605-607
47. Capino A C, Thomas A N, Baylor S, Hughes K M, Miller J L, Johnson P N. Antipsychotic Use in the Prevention and Treatment of Intensive Care Unit Delirium in Pediatric Patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2020; 25 : 81-95
48. Shaddix B P, Harkin M, Miller J L, Johnson P N. Which PGY1 Pharmacy Residency Is Right for Me? Advantages and Disadvantages of Pediatric-Focused and Traditional PGY1 Pharmacy Programs. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2020; 25 : 273-277
49. Johnson P N, Gildon B, Condren M, Miller J L, Hagemann T M, Lewis T V, John B, Farmer K. A survey of pediatric degree option program graduates in a doctor of pharmacy curriculum: Confidence and initial employment position. Currents in pharmacy teaching & learning. 2019; 11 : 1296-1302
50. Lim S Y, Woo S, Miller J L, Skrepnek G H, Henry E D, Johnson P N. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2019; 20 : e556-e564
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.